Aberrant MAP6 function may contribute to tau-independent cytoskeletal defects in neurodegeneration, and stabilizing MAP6-microtubule interactions pharmacologically could compensate for Tau pathology
Prediction: Small molecules enhancing MAP6-microtubule binding will ameliorate cytoskeletal defects in tau knockout neurons and improve neuronal survival in amyloid toxicity models
In tauopathies, pathological tau alterations may disrupt the antagonistic balance with MAP6, causing excessive stabilization and loss of adaptive plasticity, while in other conditions the relationship may be shifted toward excess lability
Prediction: MAP6 expression levels or post-translational modifications will be altered in tauopathy patient samples as a compensatory response to tau dysfunction
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
MAP6Unspecified Mechanismneurodegeneration
Convergent signals
MAP6 recurs across 2 selected hypotheses with aligned directionality in unspecified mechanism.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
1/11
dimensions won
MAP6-mediated microtubule stabilization
6/11
dimensions won
Tau/MAP6 antagonism in neurodegeneration
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.55
0.70
Evidence
0.50
0.65
Novelty
0.50
0.65
Feasibility
0.50
0.65
Impact
0.00
0.00
Druggability
0.00
0.00
Safety
0.00
0.00
Competition
0.00
0.00
Data
0.00
0.00
Reproducible
0.64
0.81
KG Connect
0.50
0.50
Score Breakdown
Dimension
MAP6-mediated microtubule stab
Tau/MAP6 antagonism in neurode
Mechanistic
0.550
0.700
Evidence
0.500
0.650
Novelty
0.500
0.650
Feasibility
0.500
0.650
Impact
0.000
0.000
Druggability
0.000
0.000
Safety
0.000
0.000
Competition
0.000
0.000
Data
0.000
0.000
Reproducible
0.642
0.815
KG Connect
0.500
0.500
Evidence
MAP6-mediated microtubule stabilization as therapeutic targe
No evidence citations yet
Tau/MAP6 antagonism in neurodegeneration progression